Form 4: CAVA Chief People Officer Manages Equity Holdings
Insider Transaction Report
CAVA Group's Chief People Officer, Kelly Costanza, executed a series of equity transactions including an RSU grant, option exercise, and share sale.
Summary
- Kelly Costanza, Chief People Officer of CAVA Group, Inc. (CAVA), engaged in multiple equity transactions on February 26, 2026.
- Received a grant of 4,721 Restricted Stock Units (RSUs) at a price of $0, which will vest in three equal annual installments starting January 24, 2027.
- Exercised 31,803 stock options at an exercise price of $6.75 per share; these options were fully vested and exercisable.
- Sold 31,803 shares of common stock at a price of $84.45 per share.
- Following these transactions, Kelly Costanza beneficially owns 123,860 shares of CAVA common stock, including unvested RSUs.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While there's a sale of shares, it's offset by a new RSU grant and the realization of value from vested options, indicating routine executive compensation management rather than a change in company fundamentals.
Positives
- The grant of 4,721 Restricted Stock Units (RSUs) at no cost provides future equity incentive and aligns management interests with shareholder value.
- The exercise of stock options indicates the executive is realizing value from previously granted equity compensation.
Negatives
- The sale of 31,803 shares of common stock, while common for tax and liquidity purposes, reduces the executive's direct ownership stake.
Future Outlook
The granted Restricted Stock Units are scheduled to vest in three equal annual installments, commencing on January 24, 2027, contingent on the reporting person's continued service.
Industry Context
StockSavvy.ai notes that these types of transactions, involving the exercise of stock options and subsequent sale of shares, often coupled with new equity grants, are standard practices for executives managing their compensation and personal financial planning, including tax obligations.
Comparison to Industry Standards
- StockSavvy.ai observes that the combination of an RSU grant, option exercise, and share sale is a common pattern for executives in publicly traded companies, aligning with typical equity compensation management strategies across various industries.
- The exercise of fully vested options and subsequent sale of shares is a routine liquidity event, often referred to as a 'sell-to-cover' transaction, which is widely observed among executives managing their equity portfolios.
Stakeholder Impact
- Shareholders: The transactions are routine and do not indicate a significant shift in company strategy or performance. The executive's continued equity holdings, including unvested RSUs, maintain alignment with shareholder interests.
- Employees: No direct impact on employees is indicated by this filing.
Next Steps
- The first installment of the granted Restricted Stock Units is scheduled to vest on January 24, 2027.
Key Dates
| Date | Description |
|---|---|
| 02/26/2026 | Date of RSU grant, stock option exercise, and common stock sale. |
| 01/24/2027 | Commencement date for the first of three equal annual vesting installments for the granted RSUs. |
| 05/10/2032 | Expiration date of the stock options that were exercised. |
Recommendation
holdThis Form 4 details routine insider transactions related to executive compensation management, including an RSU grant, option exercise, and subsequent share sale. It does not provide new fundamental information about CAVA Group's operational performance or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals.
Keywords
CAVA, Form 4, Insider Transaction, Stock Options, Restricted Stock Units, Executive Compensation, Equity Management, Kelly Costanza
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.